Stay updated on Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Recruitment status for NCT05445778 was updated to Completed on 2026-01-07, replacing the prior Recruiting status recorded in 2025.
    Difference
    0.5%
    Check dated 2026-01-10T02:04:05.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Recruitment locations have been expanded and reorganized across numerous regions and countries, with many new sites added and some existing sites removed. This changes where participants may enroll in the study.
    Difference
    4%
    Check dated 2025-12-19T15:20:15.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Revision changed from v3.3.1 to v3.3.2. No substantive study information or page functionality appears affected.
    Difference
    0.0%
    Check dated 2025-11-28T02:40:05.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The Publications section now states that PubMed publications are automatically filled from PubMed and may not be about the study; the page also shows a new Revision: v3.3.1 (replacing v3.2.0).
    Difference
    0.1%
    Check dated 2025-11-20T22:40:40.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Removed the generic government funding status notice from the page; core study details, inclusion criteria, and enrollment information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-13T16:55:37.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    No additions or deletions detected on the Study Details page; the content appears unchanged across the provided views.
    Difference
    0.1%
    Check dated 2025-10-30T11:18:32.000Z thumbnail image

Stay in the know with updates to Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial page.